header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

ARE HIGH FLEXION ACTIVITIES AFTER HIGH-FLEX TOTAL KNEE REPLACEMENT SAFE?



Abstract

Introduction To acquire high flexion has been a current topic in TKA. However, there is concern about the trade-off between high flexion and safety. The purpose of this study was to determine the factors contributing to the high rate of aseptic loosening in femoral components of LPS-flex TKAs that we experienced.

Materials and Methods: From March 2003 to September 2004, 72 consecutive TKA were performed in 47 osteoarthritic patients by a single surgeon. The high-flex design fixed total knee prostheses (NexGen LPS-Flex) were used in all knees. The weight-bearing high flexion activities such as squatting were permitted as tolerable. We retrospectively analyzed the clinical and radiological outcome of this case series.

Results: At a mean of 32 months (range, 30 to 48 months), 27 (38%) cases had shown the radiological findings of aseptic loosening around the femoral components and fifteen (21%) cases have been revised for the progression of component loosening and pain. Postoperatively, the average maximal flexion was 136º in the loosening group, which was higher than 125º in the no-loosening group (P=0.022). The percentage of patients who could squat, kneel or sit cross-legged postoperatively was greater in the loosening group (85% versus 44%) (P=0.001). The femoral component demonstrated movement into flexion, from a mean of 4° to a mean of 7° (γ angle) in the loosening group and not in the no-loosening group.

Conclusion: The high-flex implant allowed for greater range of motion and high-flexion activities, and however, showed high rate of early femoral component loosening, which was associated with weight-bearing high-flexion activities.

Correspondence should be addressed to: EFORT Central Office, Technoparkstrasse 1, CH – 8005 Zürich, Switzerland. Email: office@efort.org